Biogen stock is traded on Nasdaq and requires filing with the SEC.
4 reports, 3 independent
Updated Sep 12
Gone quiet
- Reports
- 4
- Developments
- 3
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Biogen stock is traded on Nasdaq and requires filing with the SEC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Biogen filed reports with the SEC regarding holdings, while institutional investors increased stock holdings and analyst reports influenced market perception.Sub-event
- Freedom Capital upgraded Biogen shares, and MarketBeat reported the consensus rating for the company.Sub-event
Biogen stock is traded on Nasdaq and requires SEC filing.1 source
Keep exploring
The entities involved
Related events
- HCW Biologics Inc. filed disclosures with the SEC and its shares are listed on Nasdaq.
- Monopar Therapeutics stock traded on the Nasdaq exchange and disclosed transactions via SEC filings on October 5, 2026.
- Rapport Therapeutics disclosed a stock sale in an SEC filing and is listed on Nasdaq.
- AMD stock is traded on Nasdaq, and the company filed disclosures with the SEC.
- Meta uses Nasdaq for its stock trading and files reports with the SEC.